Preferred Label : Lung Non-Small Cell Carcinoma;
NCIt synonyms : Non Small Cell Lung Cancer NOS; NSCLC - Non-Small Cell Lung Cancer; Non-Small Cell Lung Cancer; Non-Small Cell Carcinoma of the Lung; Non-Small Cell Cancer of Lung; NSCLC; Non-Small Cell Carcinoma of Lung; Non-Small Cell Cancer of the Lung; Non-Small Cell Lung Carcinoma;
NCIt related terms : Non-small cell lung cancer, NOS;
CISMeF acronym : NSCLC;
NCIt definition : A group of at least three distinct histological types of lung cancer, including non-small
cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small
cell lung carcinomas have a poor response to conventional chemotherapy.;
Alternative definition : NCI-GLOSS: A group of lung cancers that are named for the kinds of cells found in
the cancer and how the cells look under a microscope. The three main types of non-small
cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma.
Non-small cell lung cancer is the most common kind of lung cancer.;
Neoplastic status : Malignant;
Codes from synonyms : 10029514; CDR0000045323;
Origin ID : C2926;
UMLS CUI : C0007131;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Disease excludes abnormal cell
Excludes anatomical site(s)
Has associated anatomic sites
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
associated_with_malfunction_of_gene_product
concept_is_in_subset
disease_excludes_finding
disease_has_abnormal_cell
disease_has_accepted_treatment_with_regimen
disease_has_associated_gene
disease_has_finding
disease_has_normal_cell_origin
disease_has_normal_tissue_origin
disease_has_primary_anatomic_site
disease_mapped_to_gene
disease_may_have_molecular_abnormality
neoplasm_has_special_category
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-dun-panel-multigene-diagnostique-pronostique-ou-predictif-pour-le-carcinome-pulmonaire-non-a-petites-cellules-par-biopsie-liquide.html
2024
Canada
health technology assessment
Percent of Predicted Value
Evaluation
Liquid Biopsy
Have Not Been Diagnosed
lung biopsy
Panel Device
biopsy, nos
lung, nos
carcinoma, non-small-cell lung
Diagnosis
Physical Examination
Prognostic
Assessment
liquid substance, nos
Lung Non-Small Cell Carcinoma
evaluation studies as topic
Liquid Biopsy
Assessment
---
https://pgtmsite.files.wordpress.com/2024/01/ad-pembro_rapport-final1.pdf
2022
Canada
drug information
neoplasm, malignant
quebec
pembrolizumab
carcinoma, non-small-cell lung
Nonmetastatic
CYRIB wt Allele
L1 Stage Finding
Metastatic
Daur Chinese
lupus erythematosus cell
Lower Esophageal Sphincter
Lung Non-Small Cell Carcinoma
metastatic to
L1 Mouse
small cell lung carcinoma
patients
Patient
has patient
LE cells
Due
Long Interspersed Nucleotide Element-1
Pembrolizumab
Identifier
Intent To Treat
Device-In-Use Domain
Metastatic Malignant Neoplasm
Deoxyuridine
B7-H1 Antigen
pembrolizumab
pembrolizumab
intention to treat analysis
Analysis
hospitals, university
neutrophils
Cancer Therapeutic Procedure
Analyzed
Description
INRG Stage L1
---